Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
Clementine Sarkozy,Loïc Chartier, Vincent Ribrag,Remy Gressin,Christian Geisler,Hanneke Kluin-Nelemans,Catherine Thieblemont,Franck Morschhauser,Corinne Haioun,Violaine Safar,Herve Ghesquieres, Wolframm Klapper, Barbara Burroni,Christiane Pott,Marie-Helene Delfau,Elizabeth A. Macintyre, Mary Callanan,Michael Unterhalt,Eva Hoster,Martin Dreyling Blood(2023)
AI 理解论文
溯源树
样例